UnitedHealth Group is trading 3% up at $430.27 as investors rotate into defensive healthcare names during a strong sector-wide rally.
- The move builds on a recent Q2 2026 earnings beat and the company's active share repurchase program.
- Buying interest remains supported by a one-year total shareholder return exceeding 50%, despite some recent market commentary questioning current valuation levels.